Vanhoorelbeke K - Search Results

1

Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H. Broos K, et al. Among authors: vanhoorelbeke k. Thromb Res. 2012 Mar;129(3):245-9. doi: 10.1016/j.thromres.2011.11.002. Epub 2011 Nov 26. Thromb Res. 2012. PMID: 22119499 Review.

2

A platelet-activating antiglycoprotein Ib monoclonal antibody.

Deckmyn H, Vanhoorelbeke K, Cauwenberghs N. Deckmyn H, et al. Among authors: vanhoorelbeke k. Blood. 1997 Nov 1;90(9):3807-8. Blood. 1997. PMID: 9345070 Free article. No abstract available.

3

Inhibitory and activating human antiplatelet antibodies.

Deckmyn H, Vanhoorelbeke K, Peerlinck K. Deckmyn H, et al. Among authors: vanhoorelbeke k. Baillieres Clin Haematol. 1998 Jun;11(2):343-59. doi: 10.1016/s0950-3536(98)80053-x. Baillieres Clin Haematol. 1998. PMID: 10097812 Review.

4

A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor.

Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H. Vanhoorelbeke K, et al. Thromb Haemost. 2000 Jan;83(1):107-13. Thromb Haemost. 2000. PMID: 10669163

5

Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF.

Vanhoorelbeke K, van der Plas RM, Vandecasteele G, Vauterin S, Huizinga EG, Sixma JJ, Deckmyn H. Vanhoorelbeke K, et al. Thromb Haemost. 2000 Oct;84(4):621-5. Thromb Haemost. 2000. PMID: 11057860

6

Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor.

Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Deckmyn H. Cauwenberghs N, et al. Among authors: vanhoorelbeke k. Platelets. 2000 Nov;11(7):373-8. doi: 10.1080/09537100020019157. Platelets. 2000. PMID: 11132103 Review.

7

Occurrence of the Asn45Ser mutation in the GPIX gene in a Belgian patient with Bernard Soulier syndrome.

Vanhoorelbeke K, Schlammadinger A, Delville JP, Handsaeme J, Vandecasteele G, Vauterin S, Pradier O, Wijns W, Deckmyn H. Vanhoorelbeke K, et al. Platelets. 2001 Mar;12(2):114-20. doi: 10.1080/09537100020047101. Platelets. 2001. PMID: 11297032

8

Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.

Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H. Cauwenberghs N, et al. Among authors: vanhoorelbeke k. Blood. 2001 Aug 1;98(3):652-60. doi: 10.1182/blood.v98.3.652. Blood. 2001. PMID: 11468163 Free article.

9

Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.

Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, Deckmyn H. Wu D, et al. Among authors: vanhoorelbeke k. Blood. 2002 May 15;99(10):3623-8. doi: 10.1182/blood.v99.10.3623. Blood. 2002. PMID: 11986216 Free article.

10

A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.

Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H. Vanhoorelbeke K, et al. Semin Thromb Hemost. 2002 Apr;28(2):161-6. doi: 10.1055/s-2002-27818. Semin Thromb Hemost. 2002. PMID: 11992239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page